Ultrahigh-speed swept-source OCT angiography in exudative AMD.

BACKGROUND AND OBJECTIVE To investigate the potential of ultrahigh-speed swept-source optical coherence tomography angiography (OCTA) to visualize retinal and choroidal vascular changes in patients with exudative age-related macular degeneration (AMD). PATIENTS AND METHODS Observational, prospective cross-sectional study. An ultrahigh-speed swept-source prototype was used to perform OCTA of the retinal and choriocapillaris microvasculature in 63 eyes of 32 healthy controls and 19 eyes of 15 patients with exudative AMD. MAIN OUTCOME MEASURE qualitative comparison of the retinal and choriocapillaris microvasculature in the two groups. RESULTS Choroidal neovascularization (CNV) was clearly visualized in 16 of the 19 eyes with exudative AMD, located above regions of severe choriocapillaris alteration. In 14 of these eyes, the CNV lesions were surrounded by regions of choriocapillaris alteration. CONCLUSION OCTA may offer noninvasive monitoring of the retinal and choriocapillaris microvasculature in patients with CNV, which may assist in diagnosis and monitoring.

[1]  Benjamin J Vakoc,et al.  Three-dimensional microscopy of the tumor microenvironment in vivo using optical frequency domain imaging , 2009, Nature Medicine.

[2]  E. Gragoudas,et al.  Pegaptanib for neovascular age-related macular degeneration. , 2004, The New England journal of medicine.

[3]  Susan Schneider,et al.  Ranibizumab versus verteporfin for neovascular age-related macular degeneration. , 2006, The New England journal of medicine.

[4]  J S Sunness,et al.  The development of choroidal neovascularization in eyes with the geographic atrophy form of age-related macular degeneration. , 1999, Ophthalmology.

[5]  I. Bhutto,et al.  Understanding age-related macular degeneration (AMD): relationships between the photoreceptor/retinal pigment epithelium/Bruch's membrane/choriocapillaris complex. , 2012, Molecular aspects of medicine.

[6]  Martin F. Kraus,et al.  Split-spectrum amplitude-decorrelation angiography with optical coherence tomography , 2012, Optics express.

[7]  Robert J Zawadzki,et al.  Phase-variance optical coherence tomography: a technique for noninvasive angiography. , 2014, Ophthalmology.

[8]  N. Bressler.  Antiangiogenic approaches to age-related macular degeneration today. , 2009, Ophthalmology.

[9]  T. Yatagai,et al.  Optical coherence angiography. , 2006, Optics express.

[10]  Lingfeng Yu,et al.  Doppler variance imaging for three-dimensional retina and choroid angiography. , 2010, Journal of biomedical optics.

[11]  G. Ying,et al.  Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. , 2012, Ophthalmology.

[12]  Adrian Mariampillai,et al.  Speckle variance detection of microvasculature using swept-source optical coherence tomography. , 2008, Optics letters.

[13]  Changhuei Yang,et al.  Mobility and transverse flow visualization using phase variance contrast with spectral domain optical coherence tomography. , 2007, Optics express.

[14]  Manuel Guizar-Sicairos,et al.  Efficient subpixel image registration algorithms. , 2008, Optics letters.

[15]  J. Duker,et al.  Choriocapillaris and Choroidal Microvasculature Imaging with Ultrahigh Speed OCT Angiography , 2013, PloS one.

[16]  William J Feuer,et al.  An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. , 2007, American journal of ophthalmology.

[17]  Chen D. Lu,et al.  Retinal, anterior segment and full eye imaging using ultrahigh speed swept source OCT with vertical-cavity surface emitting lasers , 2012, Biomedical optics express.

[18]  U. Schmidt-Erfurth,et al.  Management of neovascular age-related macular degeneration , 2007, Progress in Retinal and Eye Research.

[19]  Martin F. Kraus,et al.  Quantitative optical coherence tomography angiography of choroidal neovascularization in age-related macular degeneration. , 2014, Ophthalmology.

[20]  R W Flower,et al.  Feasibility of extracting velocity distribution in choriocapillaris in human eyes from ICG dye angiograms. , 2006, Journal of biomechanical engineering.

[21]  Takayuki Baba,et al.  Relationship between RPE and choriocapillaris in age-related macular degeneration. , 2009, Investigative ophthalmology & visual science.

[22]  J. Duker,et al.  Analysis of short-term change in subfoveal choroidal thickness in eyes with age-related macular degeneration using optical coherence tomography. , 2014, Ophthalmic surgery, lasers & imaging retina.

[23]  Soon-Sun Kwon,et al.  COMPARISON OF CHOROIDAL THICKNESS AMONG PATIENTS WITH HEALTHY EYES, EARLY AGE-RELATED MACULOPATHY, NEOVASCULAR AGE-RELATED MACULAR DEGENERATION, CENTRAL SEROUS CHORIORETINOPATHY, AND POLYPOIDAL CHOROIDAL VASCULOPATHY , 2011, Retina.

[24]  P T de Jong,et al.  Morphometric analysis of Bruch's membrane, the choriocapillaris, and the choroid in aging. , 1994, Investigative ophthalmology & visual science.

[25]  Philip J Rosenfeld,et al.  Ranibizumab for neovascular age-related macular degeneration. , 2006, The New England journal of medicine.

[26]  Ruikang K. Wang,et al.  In vivo volumetric imaging of vascular perfusion within human retina and choroids with optical micro-angiography. , 2008, Optics express.

[27]  R. Flower,et al.  Theoretical investigation of the role of choriocapillaris blood flow in treatment of subfoveal choroidal neovascularization associated with age-related macular degeneration. , 2001, American journal of ophthalmology.

[28]  N. Bressler,et al.  Estimated cases of legal blindness and visual impairment avoided using ranibizumab for choroidal neovascularization: non-Hispanic white population in the United States with age-related macular degeneration. , 2011, Archives of ophthalmology.

[29]  R. Flower,et al.  Ten years experience with choroidal angiography using indocyanine green dye: a new routine examination or an epilogue? , 1985, Documenta Ophthalmologica.

[30]  Peter K Kaiser,et al.  Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration. , 2007, Ophthalmology.

[31]  D. S. Mcleod,et al.  Quantifying changes in RPE and choroidal vasculature in eyes with age-related macular degeneration. , 2002, Investigative ophthalmology & visual science.

[32]  Philip J Rosenfeld,et al.  A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study. , 2009, American journal of ophthalmology.

[33]  Chen D. Lu,et al.  Phase-sensitive swept-source optical coherence tomography imaging of the human retina with a vertical cavity surface-emitting laser light source. , 2013, Optics letters.

[34]  R W Flower,et al.  Extraction of choriocapillaris hemodynamic data from ICG fluorescence angiograms. , 1993, Investigative ophthalmology & visual science.

[35]  Byeong Ha Lee,et al.  Noninvasive investigation of deep vascular pathologies of exudative macular diseases by high-penetration optical coherence angiography. , 2013, Investigative ophthalmology & visual science.

[36]  R. Leitgeb,et al.  Ultrahigh-speed non-invasive widefield angiography. , 2012, Journal of biomedical optics.

[37]  Philip J Rosenfeld,et al.  Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration. , 2005, Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.